DOJ Catches Big Fish in Generic Pharmaceutical Criminal Antitrust Investigation
The Justice Department’s Antitrust Division announced a major guilty plea with Sandoz, Inc., in its expanding criminal investigation of the generic pharmaceutical industry. DOJ has been pursuing this investigation for several years with some progress, but the Sandoz guilty plea is a major accomplishment in the investigation. Sandoz agreed to pay $195 million in exchange for a three-year deferred purchase agreement (“DPA”). DOJ filed a...